{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:44:51Z","timestamp":1773355491761,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Siksha 'O' Anusandhan Deemed To Be University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04727-7","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:35:39Z","timestamp":1773315339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular changes in patients on Topiramate therapy: a hospital-based comparative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Manaswini","family":"Patro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchismita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srimant","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep Kumar","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0149-2918(97)80006-9","volume":"19","author":"WE Rosenfeld","year":"1997","unstructured":"Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther. 1997;19:1294\u2013308.","journal-title":"Clin Ther"},{"key":"4727_CR2","first-page":"12","volume":"57","author":"JA French","year":"2001","unstructured":"French JA, Kanner JR, Bautista M. Efficacy of Topiramate for Migraine Prophylaxis. Neurology. 2001;57:12\u20138.","journal-title":"Neurology"},{"key":"4727_CR3","first-page":"209","volume":"45","author":"RP Shank","year":"2000","unstructured":"Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. Pharmacological profile of topiramate: preclinical and clinical data. Epilepsy Res. 2000;45:209\u201321.","journal-title":"Epilepsy Res"},{"key":"4727_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1528-1157.2000.tb02169.x","volume":"41","author":"SJ Dodgson","year":"2000","unstructured":"Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia. 2000;41:35\u20139.","journal-title":"Epilepsia"},{"key":"4727_CR5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ophtha.2003.12.053","volume":"111","author":"FT Fraunfelder","year":"2004","unstructured":"Fraunfelder FT, Fraunfelder FW, Keates EU. Ocular side effects associated with topiramate. Ophthalmology. 2004;111:1489\u201394.","journal-title":"Ophthalmology"},{"key":"4727_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/eye.2009.37","volume":"24","author":"AM Abdelrahman","year":"2010","unstructured":"Abdelrahman AM, Al Harby S, Al Shahwan S. Pathophysiology and management of topiramate-induced angle-closure glaucoma. Eye. 2010;24:59\u201364.","journal-title":"Eye"},{"key":"4727_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjo.2005.076042","volume":"90","author":"DY Leung","year":"2006","unstructured":"Leung DY, Baig N, Barash A, Katz LJ, Moster ML, Shindler KS. Acute vision loss following topiramate therapy: case report and review. Br J Ophthalmol. 2006;90:99\u2013101.","journal-title":"Br J Ophthalmol"},{"key":"4727_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1139\/I06-012","volume":"41","author":"J Levy","year":"2006","unstructured":"Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41:221\u20135.","journal-title":"Can J Ophthalmol"},{"key":"4727_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/0301-4738.27072","volume":"54","author":"CM Desai","year":"2006","unstructured":"Desai CM, Ramchandani SJ, Bhopale SG, Ramchandani SS. Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine. Indian J Ophthalmol. 2006;54:195\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"4727_CR10","doi-asserted-by":"publisher","first-page":"NC01","DOI":"10.7860\/JCDR\/2016\/16263.7339","volume":"10","author":"O Hesami","year":"2016","unstructured":"Hesami O, Hosseini SS, Kazemi N, Hosseini-Zijoud SM, Moghaddam NB, Assarzadegan F, et al. Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache. J Clin Diagn Res. 2016;10:NC01\u20134. https:\/\/doi.org\/10.7860\/JCDR\/2016\/16263.7339.","journal-title":"J Clin Diagn Res"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/02713683.2010.529540","volume":"36","author":"BT Ozturk","year":"2011","unstructured":"Ozturk BT, Genc E, Tokgoz M, Kerimoglu H, Genc BO. Ocular changes associated with topiramate. Curr Eye Res. 2011;36:47\u201352.","journal-title":"Curr Eye Res"},{"key":"4727_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/1120672117750054","volume":"28","author":"MK Abdellatif","year":"2018","unstructured":"Abdellatif MK, Fouad MM. Effect of duration and severity of migraine on retinal nerve fiber layer, ganglion cell layer, and choroidal thickness. Eur J Ophthalmol. 2018;28:714\u201321.","journal-title":"Eur J Ophthalmol"},{"key":"4727_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15569527.2017.1311337","volume":"36","author":"M Gok","year":"2017","unstructured":"Gok M, Ozdemir O. Effect of topiramate on choroidal thickness and anterior chamber parameters in the treatment of patients with migraine. Cutan Ocul Toxicol. 2017;36:381\u20136.","journal-title":"Cutan Ocul Toxicol"},{"key":"4727_CR14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4274\/tjo.42.19480","volume":"42","author":"\u00d6 \u00d6r\u00fcm","year":"2012","unstructured":"\u00d6r\u00fcm \u00d6, Tarak\u00e7\u0131o\u011flu H, Yi\u011fit U. Topiramate-induced myopic shift and bilateral secondary angle-closure glaucoma. Turk J Ophthalmol. 2012;42:154\u20136.","journal-title":"Turk J Ophthalmol"},{"key":"4727_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41983-020-00263-3","volume":"57","author":"MN Thabit","year":"2021","unstructured":"Thabit MN, Farouk MM. Topiramate-induced ocular side effects in Egyptian patients, idiosyncratic versus dose-dependent effect, a prospective study. Egypt J Neurol Psychiatry Neurosurg. 2021;57:1\u20135. https:\/\/doi.org\/10.1186\/s41983-020-00263-3.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"4727_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/OPX.0b013e31815b9e38","volume":"84","author":"CP Guier","year":"2007","unstructured":"Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci. 2007;84:1070\u20133.","journal-title":"Optom Vis Sci"},{"key":"4727_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1177\/0333102420946736","volume":"40","author":"M Gopalakrishna","year":"2020","unstructured":"Gopalakrishna M, Odayappan A, Srinivasan K, Rengaraj V. A case series of topiramate-induced angle closure crisis - an ophthalmic emergency. Cephalalgia. 2020;40:1389\u201393.","journal-title":"Cephalalgia"},{"key":"4727_CR18","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.4103\/ijo.IJO_375_21","volume":"69","author":"G Panicker","year":"2021","unstructured":"Panicker G, Kaliaperumal S, Narayan S, Mani M. Glaucoma and optical coherence tomography changes in migraine: A comparative cross-sectional study. Indian J Ophthalmol. 2021;69:3546\u201351.","journal-title":"Indian J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04727-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:57:41Z","timestamp":1773316661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04727-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04727-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the basic tenets of the Helsinki Declaration. Written informed consent was obtained from each of them before enrolling in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Institutional ethics committee, Institute of Medical Sciences (IMS) and SUM Hospital, Siksha O Anusandhan (deemed to be a university) (ECR\/627\/Inst\/OR\/2014)\u2026.Letter number IEC\/IMS.SH\/SOA\/2024\/851 dated 06\/09\/2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Name of the committee"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}